- Home
- SAGE vs TRML Comparison
SAGE vs TRML Comparison
Compare SAGE & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- TRML
- Stock Information
- Founded
- SAGE 2010
- TRML 2021
- Country
- SAGE United States
- TRML United States
- Employees
- SAGE N/A
- TRML N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- TRML Biotechnology: Pharmaceutical Preparations
- Sector
- SAGE Health Care
- TRML Health Care
- Exchange
- SAGE Nasdaq
- TRML Nasdaq
- Market Cap
- SAGE 474.6M
- TRML 509.8M
- IPO Year
- SAGE 2014
- TRML N/A
- Fundamental
- Price
- SAGE $7.77
- TRML $13.40
- Analyst Decision
- SAGE Hold
- TRML Strong Buy
- Analyst Count
- SAGE 19
- TRML 6
- Target Price
- SAGE $9.88
- TRML $45.20
- AVG Volume (30 Days)
- SAGE 1.2M
- TRML 378.2K
- Earning Date
- SAGE 04-24-2025
- TRML 05-12-2025
- Dividend Yield
- SAGE N/A
- TRML N/A
- EPS Growth
- SAGE N/A
- TRML N/A
- EPS
- SAGE N/A
- TRML N/A
- Revenue
- SAGE $41,243,000.00
- TRML N/A
- Revenue This Year
- SAGE $100.39
- TRML $363.93
- Revenue Next Year
- SAGE $70.86
- TRML N/A
- P/E Ratio
- SAGE N/A
- TRML N/A
- Revenue Growth
- SAGE N/A
- TRML N/A
- 52 Week Low
- SAGE $4.62
- TRML $11.87
- 52 Week High
- SAGE $17.51
- TRML $29.79
- Technical
- Relative Strength Index (RSI)
- SAGE 48.49
- TRML 35.48
- Support Level
- SAGE $7.99
- TRML $16.39
- Resistance Level
- SAGE $8.81
- TRML $17.36
- Average True Range (ATR)
- SAGE 0.31
- TRML 1.09
- MACD
- SAGE -0.06
- TRML -0.38
- Stochastic Oscillator
- SAGE 9.57
- TRML 6.36
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.